Male hormonal contraception

Virtual Mentor

Volumn 14, Issue 2, 2012, Pages 126-132

  Roth, Mara Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MALE CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE; TESTOSTERONE; TESTOSTERONE DERIVATIVE;

ANIMAL; AZOOSPERMIA; CHEMICALLY INDUCED DISORDER; CONTRACEPTION; DRUG APPROVAL; DRUG COMBINATION; DRUG EFFECT; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; ILLEGAL ABORTION; MALE; OLIGOSPERMIA; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPERMATOGENESIS; TREATMENT OUTCOME; UNITED STATES; UNPLANNED PREGNANCY;

ABORTION, CRIMINAL; ANIMALS; AZOOSPERMIA; CONTRACEPTION; CONTRACEPTIVE AGENTS, MALE; DRUG APPROVAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; OLIGOSPERMIA; PREGNANCY; PREGNANCY, UNPLANNED; PROGESTERONE CONGENERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPERMATOGENESIS; TESTOSTERONE; TESTOSTERONE CONGENERS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84873988032     PISSN: 19377010     EISSN: None     Source Type: Journal    
DOI: 10.1001/virtualmentor.2012.14.2.stas1-1202     Document Type: Article

References (37)

1. Sedgh G, Henshaw S, Singh S, Ahman E, Shah IH. Induced abortion: estimated rates and trends worldwide. Lancet. 2007;370(9595):1338-1345.
2. Henshaw SK, Singh S, Haas T. The incidence of abortion worldwide. Int Fam Plann Persp. 1999;25(Suppl):S30-S38.
3. Blumenthal PD, Edelman A. Hormonal contraception. Obstet Gynecol. 2008;112(3):670-684.
4. Glasier AF, Anakwe R, Everington D, et al. Would women trust their partners to use a male pill? Hum Reprod. 2000;15(3):646-649.
5. Martin CW, Anderson RA, Cheng L, et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod. 2000;15(3):637-645.
6. Hall PF. On the stimulation of testicular steroidogenesis in the rabbit by interstitial cell-stimulating hormone. Endocrinology. 1966;78(4):690-698.
7. Amann RP, Howards SS. Daily spermatozoal production and epididymal spermatozoal reserves of the human male. J Urol. 1980;124(2):211-215.
8. Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367(9520):1412-1420.
9. Ly LP, Liu PY, Handelsman DJ. Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens. Hum Reprod. 2005;20(6):1733-1740.
10. Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16(3):231-245.
11. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril. 1996;65(4):821-829.
12. Nieschlag E. 10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception. October 22-23, 2006. Contraception. 2007;75(3):166-167.
13. Moreau C, Trussell J, Rodriguez G, Bajos N, Bouyer J. Contraceptive failure rates in France: results from a population-based survey. Hum Reprod. 2007;22(9):2422-2427.
14. Gu YQ, Wang XH, Xu D, et al. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab. 2003;88(2):562-568.
15. Gu Y, Liang X, Wu W, et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab. 2009;94(6):1910-1915.
16. Ilani N, Liu PY, Swerdloff RS, Wang C. Does ethnicity matter in male hormonal contraceptive efficacy? Asian J Androl. 2011;13(4):579-584.
17. Mommers E, Kersemaekers WM, Elliesen J, et al. Male hormonal contraception: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2008;93(7):2572-2580.
18. Qoubaitary A, Meriggiola C, Ng CM, et al. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men. J Androl. 2006;27(6):853-867.
19. Male hormonal contraceptive trial ending early [news release]. Arlington, VA: CONRAD; April 22, 2011. http://www.conrad.org/news-pressreleases63.html. Accessed January 11, 2012.
20. Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab. 2003;88(6):2673-2681.
21. Page ST, Amory JK, Anawalt BD, et al. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab. 2006;91(11):4374-4380.
22. Amory JK, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ. Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen. Contraception. 2007;75(3):218-223.
23. Mahabadi V, Amory JK, Swerdloff RS, et al. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men. J Clin Endocrinol Metab. 2009;94(7):2313-2320.
24. Attardi BJ, Hild SA, Reel JR. Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity. Endocrinology. 2006;147(6):3016-3026.
25. Attardi BJ, Enbring JA, Gropp D, Hild SA. Development of dimethandrolone 17beta-undecanoate (DMAU) as an oral male hormonal contraceptive: induction of infertility and recovery of fertility in adult male rabbits. J Androl. 2011;32(5):530-540.
26. von Eckardstein S, Noe G, Brache V, et al. A clinic trial of 7-alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J Clin Endocrinol Metab. 2003;88(11):5232-5239.
27. Kumar N, Didolkar AK, Monder C, Bardin CW, Sundaram K. The biological activity of 7-alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone. Endocrinology. 1992;130(6):3677-3683.
28. Noe G, Suvisaari J, Martin C, et al. Gonadotrophin and testosterone suppression by 7alpha-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men. Hum Reprod. 1999;14(9):2200-2206.
29. Anderson RA, Martin CW, Kung AW, et al. 7alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men. J Clin Endocrinol Metab. 1999;84(10):3556-3562.
30. Wang C, Cunningham G, Dobs A, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004;89(5):2085-2098.
31. Young NR, Baker HW, Liu G, Seeman E. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception. J Clin Endocrinol Metab. 1993;77(4):1028-1032.
32. Herbst KL, Anawalt BD, Amory JK, Matsumoto AM, Bremner WJ. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone. J Clin Endocrinol Metab. 2003;88(3):1167-1173.
33. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Longterm effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 1997;82(8): 2396-2390.
34. Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 2008;93(3):914-919.
35. Fernandez-Balsells MM, Murad MH, Lane M, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010;95(6):2560-2575.
36. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109-122.
37. Malkin CJ, Pugh PJ, Morris PD, Asif S, Jones TH, Channer KS. Low serum testosterone and increased mortality in men with coronary heart disease. Heart. 2010;96(22):1821-1825.